Targeting De Novo Lipogenesis and the Lands Cycle Induces Ferroptosis in KRAS-Mutant Lung Cancer

Investigators demonstrated that FASN, the rate-limiting enzyme in fatty acid synthesis, while being dispensable in EGFR-mutant or wild-type KRAS lung cancer (LC), was required for the viability of mutant KRAS LC cells.